Product and Licensing Portfolio


Labtec's product portfolio
Our portfolio encompasses both proprietary developments and new products developed for specific pharmaceutical companies.

In the last few years our activities have focused on indications related to the central nervous system and pain management. In addition to development, since 2009 we also have the capability to manufacture transdermal patches and oral dissolvable films.

TDS Technology
API
Indication
Generic
Partner
FentanylChronic pain
x
Ratiopharm
SufentanilChronic pain
-
Open for licensing
BuprenorphineChronic pain
x
Confidential
DonepezilAlzheimer's
-
Open for licensing
Confidential APIAlzheimer's
x
Open for licensing
RasagilineParkinson's
-
Open for licensing
Development status of Labtec's transdermal systems (TDS)
API
Pre-Clinical
Phase
I
Phase II/III
Submission
Market
Fentanyl■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■
Sufentanil■■■■■■■■■■■■■■■■■■■■
Buprenorphine■■■■■■■■■■■■■
Donepezil■■■■■■■
Rasagiline■■■■


Topical Technology
API
Indication
Generic
Partner
AcyclovirCold Sores
-
Confidential
SertaconazoleOnychomychosis
-
Trommsdorff Arzneimittel, Bayer HealthCare
Essential Oils
(Vapour Patch)		Common Cold
-
Various; open for licensing in Germany
Development status of Labtec's topical patches
API
Pre-Clinical
Phase
I
Phase II/III
Submission
Market
Acyclovir■■■■■■■■■■■■■■
Sertaconazole■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■
Essential Oils■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■


Rapidfilm® Technology
API
Indication
Generic
Partner
OndansetronEmesis
x
Open for licensing
DonepezilAlzheimer\'s
x
Open for licensing
OlanzapineSchizophrenia
x
Open for licensing
ZolmitriptanMigraine
x
Open for licensing
AripiprazoleSchizophrenia
x
Open for licensing
Development status of Labtec's oral dissolvable films
API
Pre-ClinicalClinical TestingSubmissionMarket
Ondansetron■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■
Donepezil■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■
Olanzapine■■■■■■■■■■■■■■■■■■■■■ ■■■■■■■■■■
Zolmitriptan■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■
Aripiprazole■■■■■■■■■■■■■■■■■■■■■
The Rapidfilm® products containing the active pharmaceutical ingredients ondansetron, donepezil, olanzapine, and zolmitriptan are all joint ventures with APR Applied Pharma Research S.A., Switzerland.
Further information on the topic:
Labtec - We deliver.
Let our experience be your benefit

We can explore the feasibility of a full development program and assess a program’s chances of success. Labtec's new manufacturing site is equipped with the latest coating, converting and packaging technologies. Let our experts create a market opportunity for you. >>

Labtec's product portfolio
Product and Licensing Portfolio

Our portfolio encompasses both proprietary developments and new products developed for specific pharmaceutical companies. In the last few years our activities have focused on indications related to the central nervous system and pain management. In addition to development, since 2009 we also have the capability to manufacture transdermal patches and oral dissolvable films. >>

Login Labtec
Product Info

In this area you can download specific information on Labtec's products and developments. >>